Invictus MD Strategies Corp (TSX-Venture:GENE) emerged Monday with news that its subsidiary has received a sales license for its Delta location from Health Canada, pursuant to the Access to Cannabis for Medical Purposes Regulations.
The Delta Facility in question includes a cultivation, production and research facility, designed to highlight the company’s capabilities as producers and breeders of superior cannabis strains.
CEO George Kveton exulted, "We are thrilled to have achieved another major milestone with our second sales license awarded by Health Canada. We have hit the ground running in 2019, remaining laser focused on our objective to bring new facilities online to cultivate unique strain varieties required for our medical and adult use recreational product portfolio."
Invictus MD shares sprinted 10 cents, or 9.4%, to $1.16, on volume of 411,000 shares
